Tokyo

London

New York

Register

Sign In

EUR/USD

1.1664

0.0036

0.31%

GBP/USD

1.2995

0.0029

0.23%

USD/JPY

111.13

-0.7425

-0.66%

USD/CHF

0.9459

-0.0056

-0.59%

EUR/GBP

0.8976

0.0008

0.08%

USD/CAD

1.2542

-0.0054

-0.43%

NZD/USD

0.7455

0.0052

0.71%

EUR/JPY

129.61

-0.4680

-0.36%

EUR/CHF

1.1033

-0.0031

-0.28%

Peregrine Pharmaceuticals Inc.

NASDAQ: PPHMHealthcare / Biotechnology / USA
4.60-0.62-11.88%Vol 482 0581Y Perf 72.93%
Jul 21st, 2017 16:00
BID4.51 ASK4.75
Open5.14 Previous Close5.22
Pre-Market- After-Trading4.75
 - -%  0.15 3.26%
Target Price
14.00 
Analyst Rating
Strong Buy 1.00
Potencial %
204.35 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
    32.34
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)235 
Earnings Rating
Neutral
Price Range Ratio 52wk %
69.11 
Earnings Date
14th Sep 2017

Today's Price Range

4.455.26

 

52wk Range

1.965.78

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
815.79%
3 Months
800.00%
6 Months
1700.00%
1 Year
72.93%
3 Years
214.46%
5 Years
306.23%
Last Quotes
Name / TickerPriceChg.Chg.%
PPHM4.60-0.6200-11.88
AAPL150.27-0.0700-0.05
GOOG972.924.77000.49
MSFT73.79-0.4300-0.58
XOM80.12-0.7400-0.92
WFC54.17-0.7100-1.29
JNJ135.31-1.2600-0.92
FB164.43-0.1000-0.06
GE25.91-0.7800-2.92
JPM90.89-0.3100-0.34
...

TickerPriceChg.%52 Week High
CTAS138.439.19139.39
COF87.948.5596.92
ETFC41.635.1341.83
SYF30.874.5438.06
MCO132.574.25133.62
FITB26.182.7128.97
NFLX188.542.69191.50
KMX66.092.6669.11
VRTX163.172.41167.00
AAP105.271.98177.83
CCI99.171.95104.68
DFS62.531.8974.33
AEP69.981.8672.97
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.70
Current Ratio 1.20
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -17 384.50
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin38.10
EBIT Margin-59.40
EBITDA Margin-55.20
Pre-tax Profit Margin-146.50
Profit Margin-57.61
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.93
PS Ratios 5.97
Price to Cash Flow -
Price to Free Cash Flow -7.40
Cash Flow Per Share -0.95
Price to Tangible Book5.93
Book Value per Share0.94
Enterprise Value (in ths.)195 791
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-117.70
ROE last 12 Months -78.90
Return on Assets (5Y Avg) -33.99
ROA last 12 Months -34.22
Return on Capital (5Y Avg) -113.67
ROC last 12 Months -78.98
Return on invested Capital Q -22.48
Return on invested Capital Y-111.53
Assets Turnover0.40
Receivables Turnover9.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)39 726
Revenue per Share 0.93
Revenue Growth 3 Years 23.75
Revenue Growth 5 Years 22.28
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017-0.07-0.16-128.57
Q03 2017-0.21-0.28-33.33
Q02 2017-0.21-0.1433.33
Q01 2017-0.28-0.35-25.00
Q04 2016-0.21-0.35-66.67
Q03 2016-0.49-0.56-14.29
Q02 2016-0.09-0.0722.22
Q01 2016-0.08-0.080.00
Earnings Per EndEstimateRevision %Trend
4/2017 QR-0.01--
4/2017 QR-0.0166.67Positive
4/2018 FY-0.3522.22Positive
4/2018 FY-0.0516.67Positive
Next Report Date14th Sep 2017
Estimated EPS Next Report-0.12
Estimates Count1
EPS Growth Next 5 Years %0.00
Volume Overview
Volume482 058
Shares Outstanding (in ths.)45 070
Trades Count1 927
Dollar Volume2 240 919
Avg. Volume372 172
Avg. Weekly Volume468 392
Avg. Monthly Volume441 021
Avg. Quarterly Volume226 866

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

83%17%

Bearish Bullish

100%0%

Bearish Bullish

86%14%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

Plus500
x